ADMA ADMA Biologics Inc

4.87
0  -1%
Previous Close 4.93
Open 4.96
Price To book 0.00
Market Cap 62.75M
Shares 12,886,000
Volume 12,576
Short Ratio 2.42
Av. Daily Volume 33,685

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued July 29 2016. Third-party manufacturing issues cited.
RI-002
Primary Immune Deficiency Diseases

Latest News

  1. ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
  2. ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
  3. ADMA BIOLOGICS, INC. Financials
  4. ADMA Biologics Reports Year End 2016 Financial Results, Accomplishments and Upcoming Milestones
  5. ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
  6. ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
  7. ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu
  8. ADMA Biologics upgraded by Maxim Group
  9. ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation and Become a Vertically Integrated Commercial Plasma Products Company
  10. ADMA Biologics Inc (ADMA): Does It Stack Up To Its Peers?
  11. ADMA: Incremental Progress on CMC Issue Resolution.
  12. ETFs with exposure to ADMA Biologics, Inc. : November 16, 2016
  13. ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
  14. ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
  15. ADMA BIOLOGICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S
  16. ETF’s with exposure to ADMA Biologics, Inc. : September 21, 2016
  17. ADMA BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
  18. ADMA - Reviewing 2Q:16 Results; Waiting for Clarity on Resubmission Timeline
  19. ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
  20. ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi